There are no standardized guidelines/protocols for conducting common laboratory investigations during pregnancy. Here is an attempt to educate Pregnant ladies in this important aspect of their healthcare.
Common Lab Investigations in pregnancy specific to each TrimesterDrNisheethOza
There are no standardized guidelines/protocols for conducting common laboratory investigations during pregnancy. Here is an attempt to educate Pregnant ladies in this important aspect of their healthcare.
Common Lab Investigations in pregnancy specific to each TrimesterDrNisheethOza
There are no standardized guidelines/protocols for conducting common laboratory investigations during pregnancy. Here is an attempt to educate Pregnant ladies in this important aspect of their healthcare.
Pregestational diabetes a major obstetrical problem now a days. These PPT contains modern as well as Ayurveda aspect for preventing a pregnant women & her baby from developing complications.
Dr Anil Arora address the liver diseases that are specific during pregnancy. The presentation contains case discussions on diagnosis, treatments & take home messages
This talk was delivered for postgraduates and faculty of Dr. TMA Pai Hospital, Udupi on 07 March, 2017. This talk covered pathophysiology, screening, diagnosis, complications and management of diabetes mellitus in pregnancy.
Baseline serum chemistry in 1st trimesterRohit Jain
ppt on "baseline serum chemistry in 1st trimester" by Dr.Rohit Jain,Assistant Professor,Obstetrics and Gynecology Department,Civil Hospital,BJ Medical College,Ahmedabad
What do you mean by Anomaly? What are its types? Is Anomaly Scan a ‘MUST’?
In our family there has been no case of Anomaly.
I have already undergone FTS, So will it give any additional information?
Can it guarantee that my fetus is 100% normal? If an abnormality is found, can it be cured?
What options are available if an Anomaly is detected?
Can it Surely (100%) rule out Down’s Syndrome?
Can Anomaly be 100% prevented?
If such questions arise in your mind, please watch my eight small videos on this subject.
Pregestational diabetes a major obstetrical problem now a days. These PPT contains modern as well as Ayurveda aspect for preventing a pregnant women & her baby from developing complications.
Dr Anil Arora address the liver diseases that are specific during pregnancy. The presentation contains case discussions on diagnosis, treatments & take home messages
This talk was delivered for postgraduates and faculty of Dr. TMA Pai Hospital, Udupi on 07 March, 2017. This talk covered pathophysiology, screening, diagnosis, complications and management of diabetes mellitus in pregnancy.
Baseline serum chemistry in 1st trimesterRohit Jain
ppt on "baseline serum chemistry in 1st trimester" by Dr.Rohit Jain,Assistant Professor,Obstetrics and Gynecology Department,Civil Hospital,BJ Medical College,Ahmedabad
What do you mean by Anomaly? What are its types? Is Anomaly Scan a ‘MUST’?
In our family there has been no case of Anomaly.
I have already undergone FTS, So will it give any additional information?
Can it guarantee that my fetus is 100% normal? If an abnormality is found, can it be cured?
What options are available if an Anomaly is detected?
Can it Surely (100%) rule out Down’s Syndrome?
Can Anomaly be 100% prevented?
If such questions arise in your mind, please watch my eight small videos on this subject.
Pregnancy में Ultrasonography कितनी बार? कब? और क्यों? क्या ये सेफ है? जब एक गर्भवती महिला अपने डॉक्टर के पास जांच के लिए जाती हैं, तब डॉक्टर कभी कभी उसे Ultrasonography करवाने की सलाह देते है. अक्सर ये प्रश्न पूछा जाता है की Ultrasonography किस उद्देश्य से करवानी चाहिये? यह विषय मैने सरल तरीकेसे समझाया है.
When a lady visits her Obstetrician, she may be advised Ultrasonography Scan at some stage in pregnancy. It is a frequently asked question as to how many scans should she undergo during pregnancy? When? Why? (for what purpose?). I have explained this in simplified manner. Ultrasonography is an ideal and safe screening tool in pregnancy.
NT SCAN (11-13.6 weeks) & Serum BIOPROFILEDrNisheethOza
'Is everything normal?'
'Is everything fine?'
'Is my baby (fetus) alright?'
'I hope my journey through 9 months will be smooth & safe!'
'My relative's baby delivered prematurely in 8th month.'
'My Friend developed swelling & high Bp in 8th month & her baby did not grow to expected weight.'
If you wonder and worry about these questions, please go through this sides and learn the correct answers and help yourselves n choosing the right tests at the right time and prevent, predict early diagnose pregnancy complications & get timely help in case if they develop.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Common Lab Investigations in pregnancy with reference to Anaemia, Leukocytosis, Thrombocytopenia and GDM
1. COMMON LAB. INVESTIGATIONS
IN PREGNANCY
With specific reference to Anaemia, Leukocytosis,
Thrombocytopenia, GDM.
Dr. NISHEETH M. OZA
2. Dr. Nisheeth M. Oza
M.D., D.G.O., F.C.P.S., D.N.B., (M.N.A.M.S.) (OBGYN)
D.A., M.B.B.S., Dip. YAN
Obstetrician, Gynaecologist, Infertility Consultant,
FMF Certified Ultrasonographer (FMF ID 145907)
Licensed for Aneuploidy Screening NT, NB, DV, Cervix & PIH Screening.
Diploma in Yoga, Ayurveda & Naturopathy
Dr. Oza’s Hospital 87/7, Panvel 410206, Maharashtra India.
Email : drnmozas@gmail.com
Website : drozashospital.com
YouTube : DrOzaConnects
3. INTRODUCTION
When a Lady visits her Doctor during her pregnancy, she may be asked to undergo
certain Laboratory Investigations at several times, e.g.
In her first visit,
At 11-14 weeks,
At 26-28 weeks,
At 34-36 weeks,
She may wonder as to
Whether the Lab. Investigations are necessary?
WHICH? WHEN? WHY?
4. AIM OF LAB. INVESTIGATIONS – WHY?
• As a part of Prenatal (Antenatal) Care.
• To ascertain the well being of P.W. eg Her Haemoglobin test.
• To find out the conditions that may increase the risk of complications eg GDM
(BS/DIPSI Test), UTI (Urine C/S), Hypothyroidism (S. TSH).
• To find out conditions that may need special care & management eg Rh Negative,
Haemoglobinopathy or STI.
• To find out the conditions that may modify the management of P.W. & her N.B. eg
HIV positive.
5. WHEN?
• FIRST TRIMESTER/FIRST VISIT :
Antenatal Profile – Antenatal Panel.
May combine it with Genetic Screening Tests at 11-24 weeks.
• SECOND TRIMESTER 24-48 WEEKS :
GDM, UTI, Anaemia.
• THIRD TRIMESTER 35-37 WEEKS :
GBS (Group B Streptococcal Vaginal Culture).
UTI, Anaemia, Pre-eclampsia.
6. FIRST TRIMESTER/FIRST VISIT LAB. TESTS
MOST IMPORTANT: HbA1C, S. TSH.
MINIMUM : CBC, Bl. Group & Rh type, HbA1C/DIPSI Test, S.TSH. Urine-R/M including
Dipstick (Protein, Sugar, Pus cells, Nitrite).
PREFERABLE : HIV, HBsAg, HCV, VDRL.
BT, CT, PT.
Urine C/S.
OFFERED : Hb Electrophoresis – Abnormal Hb Study (Hb HPLC).
Rapid Malaria Test (kit), Thick & Thin Smear.
PAP Smear (Cytology).
Rubella IgG.
FUTURE : COVID-19 IgG, IgM.
Note: These may be combined with Genetic Screening Tests recommended between 11and 14 weeks, If
not performed prior to that.
7. SECOND TRIMESTER: 24-28 WEEKS
• CBC
• DIPSI TEST, SOS OGTT
• Urine Dipstick (Protein, Sugar, Pus Cells, Nitrate)
THIRD TRIMESTER: 35-37 WEEKS
• CBC
• Urine Dipstick (Protein, Sugar, Pus Cells, Nitrate)
• SOS Serum Creatinine, Serum Uric Acid
• Group B Streptococcal Vaginal Culture (GBS)
• Before Delivery : As per prevailing Protocol : COVID-19 rt PCR.
8. WHICH TESTS ? WHAT IS THE SIGNIFICANCE?
A] CBC
COMPONENT CRITICAL VALUE FUNCTIONS
Hb < 8 grams% Carrying Oxygen to Tissues.
WBC > 15,000/cu mm Fighting against Germs.
Platelet Count < 1,00,000/ cu mm Facilitate Blood Clotting.
Mentzer Index < 13 Indicates Possibility of
Haemoglobinopathy.
9. LOW HB LEVEL: ANAEMIA IN PREGNANCY
FUNCTION OF Hb : Carrying Oxygen to Tissues of P.W. & her fetus.
PHYSIOLOGICAL : Plasma Volume(Liq. Component), more (50%) then RBC Vol.
CHANGES (Solid Component) (30%), thereby Haemodilution, Hb by around 1 to 2 gm/dl.
DEFINITION (WHO) : Hb < 11 grams/dl.
INCIDENCE : Affects > 40% P.W. world wide.
DETERMINE : Severity : Mild: Hb 10-10.9 gm/dl, Mod: 7.0-9.9 gm/dl,
Severe: 4-6.9 gm/dl, Very Severe Hb < 4 gm/dl.
Type e.g. Microcytic Hypochromic.
Causes e.g. Iron-Deficiency.
10. SINGNIFICANCE :
1) Severe Anaemia contributes to and increases risk of death in P.W. (Maternal
Mortality).
2) Increases ill Health (Morbidity) e.g. Increases Susceptibility to Infections,
Increases need for Blood Transfusion, Increases risk of Postpartum Depression.
3) Increases Obstetric Complications e.g. Pre-eclampsia, Abruptio-Placentae,
Preterm Birth, LBW babies.
4) Increases Adverse Fetal Outcome – FGR, PNMR.
5) Newborn: Increased NMR, Abnormal Auditory Maturation.
6) Child : Impaired Psychomotor & Mental Development, Increased Cognitive &
behavioral abnormalities.
11. TREATMENT : IRON DEFICIENCY ANAEMIA
DIET : Green Leafy Vegetables, Jaggery.
DEWORMING : Albendazole, Mebendazole, after 13 weeks.
TREATMENT :
ORAL IRON : Elemental Iron 100-200 mg/day.
Problems : Tolerance, Compliance, GI side effects.
Supportive treatment: For side effects like Constipation.
PARENTERAL IRON: I.V. Iron Sucrose.
I.V. Ferric Carboxymaltose.
BLOOD TRANSFUSION : Rarely required eg. If Hb < 6 grams% & patient is in Third
Trimester of Pregnancy.
12. INCREASE IN WBC COUNT : LEUKOCYTOSIS IN PREGNANCY
FUNCTIONS OF WBC : Fighting against Germs (micro-organisms).
PHYSIOLOGICAL : Total WBC (White Blood Cell) Count increases in pregnancy, particularly the
Neutrophils, to help her fight against germs.
Especially when she is nearing EDD, during Labour & during puerperium.
WBC count upto 15,000/cumm is normal, especially Near Term During Labour,
WBC count 25,000/cumm is normal.
PATHOLOGICAL : Severe Pre-eclampsia.
CAUSES Stress, Intense Exercise, Trauma, Surgery.
Antenatal Infections : Cold, UTI, Eye Infections.
Infection During Labour or During Puerperium, Autoimmune disease like
Rheumatoid Arthritis, SLE.
TREATMENT : According to the cause, e.g. UTI-Urine C/S – Appropriate Antibiotics
Supportive care – Paracetamol for fever , personal Hygeine, Improving Immunity.
13. DECREASE IN PLATELET COUNT : THROMBOCYTOPENIA IN PREGNANCY
FUNCTION OF PLATELET : Help in and facilitating Blood Clotting Process.
PHYSIOLOGICAL : Platelet Count decreases in 10% pf P.W. especially between 30 & 40 weeks
to level below 1,50,000/cumm.
CHARACTERISTICS : No H/o low Platelet Count before conceiving, count is >70,000/cumm, No
H/o Bleeding, Count returns to normal within 12 weeks after delivery.
CRITICAL VALUE in Pregnancy is <1,00,000/cumm.
PATHOLOGICAL : Malaria, Dengue.
Pre-eclampsia, HELLP Syndrome (21%).
Immune Thrombocytopenia (ITP) 4%.
Less common: SLE,ALPA,TTP-HUS, Acute Fatty Liver of Pregnancy, DIC, HIV
infection, Hypersplenism & Medications.
TREATMENT : According to the cause.
14. ABO BLOOD GROUP & Rh TYPE
BLOOD GROUPS : A, B, AB, O.
Rh TYPES : Rh Positive, Rh Negative.
SIGNIFICANCE : In some complications during pregnancy, Labour or Puerperium, P.W. may require
Blood Transfusion.
If Pregnant women is Rh-Negative, Certain additional investigations & treatment
are required.
15. Inj. Anti D 300 mcg at 28 weeks Monitor P.W. with Col.Doppler MCA-PSA
After Delivery
Newborn’s Blood group IUT SOS, Timely Delivery.
No Further Action Adm. Inj Anti D 300 mcg to P.Mother within 72 hours
Watch for NB Jaundice -> Management-Phototherapy
P.W IS Rh Negative
Test her Husband-Blood group & Rh Type
Husband Rh Negative
No Further Test/Action
Husband Rh Positive
W:Anti Rh Ab – Early pr. & 28 weeks
Negative Positive
Rh Negative Rh Positive
16. HbA1C, BS-F & PP, DIPSI TEST , OGTT
AIM : To detect GDM-Gestational Diabetes Mellitus & Manage it.
To differentiate between PGDM-Pregestational Diabetes Mellitus & GDM if not
previously known to be Diabetic(PGDM); with the help of HbA1C in 1st Trimester.
To Identify women at the greatest risk for Congenital Malformations of fetus :from
HbA1C levels in 1st Trimester.
INCIDENCE : GDM 90% & PGDM 10% of all cases of Diabetes Mellitus in Pregnancy.
GDM in India 4 to 21 %
30% of GDM patients do not have risk factor, hence Universal screening is
recommended.
17. MALFORMATION RISK : Haemoglobin A1c Major Malformation
< 6% 2-3%
6-7 % 5-10%
8-10 % 10-25%
>10% >25%
METHODS :
HbA1C (GLYCOSYLATED HAEMOGLOBIN)
It represents glycaemic control (sugar level) in previous three months.
Hence it can differentiate GDM from PGDM if performed in 1st Trimester.
HbA1C > 6.5% in 1st Trimester – implies PGDM
Target : In each Trimester 6% or less.
BS (BLOODSUGAR) FASTING & PP (POST PRANDIAL)
Venous blood Sugar In 1st trim PGDM
Fasting : >126 mg/dl
Post Prandial : >200 mg/dl
Target: Fasting BS < 100 mg/dl.
2 hours Post Lunch <120 mg/dl.
18. DIPSI TEST
DIABETES IN PREGNANCY STUDY GROUP OF INDIA TEST
It is simple ,less cumbersome, cost effective, easily acceptable, efficient screening test, may be performed in
each trimester.
WHEN? : At first antenatal visit, then repeat between 24and 28 weeks.
HOW? : No need of fasting status.
75 gram of glucose mixed with 300 ml of water , is consumed by PW, slowly over 5 to 10 minutes,
after two hours test the blood glucose level. .
NORMAL : Blood glucose < 140 mg/dl.
CRITICAL : Blood glucose > 140 mg/dl – GDM 15% require OGTT to confirm diagnosis
: Blood glucose > 200 mg/dl – Diagnostic for GDM [ OGTT not needed]
NOTE It the vomits within 30 minutes after drinking, conduct the test on another day .
If PW vomits after 30 minutes of consumption, go on with the test.
19. OGTT
ORAL GLUCOSE TOLERANCE TEST
WHEN? : For definitive diagnosis of GDM.
If Random BS or DIPSI Test is 140-150 mg/dl.
At 28 weeks of pregnancy if first Trimester Screening was negative.
HOW? : 75 grams glucose challenge.
Fasting overnight for at least 8 hours (not > 14 hours).
CRITICAL VALUES : Venous glucose Concentration for diagnosis of DM
NDDG(mg/dl) Carpenter & Counstan(mg/dl)
Fasting 105 95
1-hour 190 180
2-hour 165 155
3-hour 145 140
--------------------------------------------------------------------------------------------------------------------------------------------------------
NDDG : National Diabetes Data Group
Carpenter & Coustan. Am J Ob Gyn 1982
20. WHY BOTHER TO SCREEN FOR GDM? CONSEQUENCES
I MATERNAL:
• Increased risk for Pre-eclampsia, Caesarean Delivery.
• 60% of GDM may develop over type 2 Diabetes Mellitus within 16 years, and may have shortened
life expectancy due to Cardiovascular disease.
II FETAL AND NEONATAL:
• Excessive fetal growth and birth trauma, including Shoulder Dystocia, Neonatal Hypoglycaemia,
Hypocalcaemia, Hyperbilirubinemia.
• Increased Perinatal Mortality associated with significant Maternal Hyperglycemia (uncontrolled) :
Class A2 Diabetes i.e. requiring Diet, Exercise & Insulin or Metformin.
21. ANTEPARTUM MANAGEMENT OF GDM
VISIT : 1-2 weeks until 36 weeks, then weekly.
DIET : 3 meals, bedtime snack.
2000-2200 Kcal/day.
Carbo 40-50% Protein 20%, Fat 30-40%, High fibre.
WEIGHT GAIN : Depending on BMI.
EXERCISE : Regular Exercise, 30 minutes moderate exercise (brisk walking).
SURVEILLANCE : SMBG- Self Monitoring of Capillary Blood Glucose.
If Fasting >95 mg/dl, 1 hour >140 mg/dl &/or 2 hour>120 mg/dl, Acid Insulin
(preferable) or Metformin.
INSULIN : 1st Trimester 0.8 u/kg 2nd Trimester 1.0 u/kg 3rd Trimester 1.2 u/kg.
50% as Basal Insulin (NPH)- 2/3rd fasting 1/3rd bedtime.
50% as Prandial Insulin (Insulin Lispro or As part).
22. METFORMIN : If patient refuses Insulin or If cost is the problem. 500 mg with dinner increases upto
1000 mg twice a day.
Side Effects : 10-25% transient GI side effects. 40% may need supplemental Insulin.
Does cross placenta, but no adverse Fetal/Neonatal/Child effects.
DELIVERY : Well controlled on Diet & Exercise ; 39-40 weeks.
suboptimally controlled – before 39 weeks.
PIH or Prior SB or class A2 NST twice a week from 32 weeks.
SFH & USG – W/F excessive fetal growth.
Wt > 4500 gm – LSCS
Wt 4000-4500 gm, consider prior obstetric history, pelvic capacity Alert Neonatal
Team- Hypoglycaemia, Hypocalacemia, Hyperbilirubinaemia.
Encourage breast feeding.
23. POST PARTUM CARE
SMBG 24-72 hours after delivery.
4-12 weeks fasting glucose or 75 gm oral GTT.
VALUES FOR VENOUS PLASMA GLUCOSE (mg/dl)
Time Normal Prediabetes Diabetes Mellitus
Fasting <100 100-125 >126
2 hrs after 75 gm <140 140-199 > 200
If normal, evaluate annually Fasting or HbA1C and every 1-3 years with 75 gm OGTT.
Encourage exercise & if obese, weight loss.
OCs : Low dose pills-No Carbohydrate intolerance.
RECURRENCE RISK IN SUBSEQUENT PREGNANCIES 40-60%
Testing for GDM in subsequent pregnancies.